Tag: RADR AI platform

Lantern-Pharma

Lantern Pharma completes LP-300 Lung cancer trial signup

Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform,…

By

NewsDesk

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions